EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia

David J Arpin iD, S H Subramony iD, READISCA Consortium, David E Vaillancourt, Tetsuo Ashizawa, Alexandra Durr, Thomas Mareci, Thomas Klockgether, Jennifer Faber, Henry L Paulson, Gülin Öz iD, Matthew R Burns

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70116 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von David J Arpin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, White Matter, Diffusion Magnetic Resonance Imaging, Machado-Joseph Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, the National Center for Advancing Translational Sciences, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Spinocerebellar ataxias (SCAs) are a group of genetically heterogeneous neurodegenerative diseases causing progressive deterioration and reduced quality of life. Therapeutic advances have been limited by a lack of sensitive anatomic, functional, or diffusion imaging‐based biomarkers. This study aimed to identify white matter differences in the brains of preataxic and early‐stage SCA1 and SCA3 mutation carriers using diffusion magnetic resonance imaging data from a multisite trial setting.

Methods

Fixel‐based analysis was used to estimate microscopic fiber density, macroscopic fiber‐bundle cross‐section, and a combined fiber density and fiber‐bundle cross‐section measure within 45 cerebral and cerebellar tracts. Multivariate ANOVAs compared controls ( n = 16), pre‐ataxic ( n = 10 SCA1, n = 24 SCA3), and ataxic patients ( n = 14 SCA1, n = 36 SCA3). Clinical variables were correlated with fixel metrics and receiver operating characteristic analyses identified white matter tracts sensitive to distinguishing controls from pre‐ataxic SCA1 and SCA3.

Results

We found widespread white matter deficits in pre‐ataxic and ataxic patients compared to controls with regard to fiber density, fiber‐bundle cross‐section, and combined measures, all of which were associated with clinical measures of ataxia severity. We also found the combined fiber density and fiber‐bundle cross‐section measure from cerebellar tracts distinguished controls from pre‐ataxia with high sensitivity and specificity for both SCA1 (receiver operating characteristic area under the curve = 0.96) and SCA3 (area under the curve = 0.97). The receiver operating characteristic analyses revealed that cerebellar tracts resulted in greater area under the curve than cortico‐spinal and transcallosal tracts.

Interpretation

These results demonstrate that fixel metrics offer sensitive disease‐specific measures of early SCA disease state that correlate with standard clinical measures. Trial Registration Clinical Trial Readiness for SCA1 and SCA3 (READISCA), NCT03487367. https://clinicaltrials.gov/ct2/show/NCT03487367 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinocerebellar AtaxiasWhite MatterDiffusion Magnetic Resonance ImagingMachado-Joseph DiseaseHumansMaleFemaleMiddle AgedAdultAgedCerebellum

Stichwörter der Autor:innen

early‐stage SCAneurodegenerationwhite matter

Autor:innen und Institutionen

  • Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, Florida, USA.
  • Department of Neurology, University of Florida, Gainesville, Florida, USA.
  • Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA.
  • Stanley H. Appel Department of Neurology, Weill Cornell Medicine at Houston Methodist Hospital, Houston, Texas, USA.
  • Sorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hopital de la Pitié-Salpêtrière, Paris, France.
  • German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

ORCID-Profile: David J Arpin, S H Subramony, Gülin Öz

Förderung

  • NIBIB NIH HHS
  • the National Center for Advancing Translational Sciences
  • NINDS NIH HHS
  • the Institutional Center Cores for Advanced Neuroimaging
  • NIH HHS
  • National Ataxia Foundation
  • ODCDC CDC HHS
  • the National Science Foundation

Zitieren

APA

Arpin, D. J., Subramony, S. H., READISCA Consortium, Vaillancourt, D. E., Ashizawa, T., Durr, A., Mareci, T., Klockgether, T., Faber, J., Paulson, H. L., Öz, G., & Burns, M. R. (2025). Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70116

Vancouver

Arpin DJ, Subramony SH, READISCA Consortium, Vaillancourt DE, Ashizawa T, Durr A, et al. Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70116

BibTeX
@article{Arpin2025,
  author = {Arpin, David J and Subramony, S H and READISCA Consortium, READISCA Consortium and Vaillancourt, David E and Ashizawa, Tetsuo and Durr, Alexandra and Mareci, Thomas and Klockgether, Thomas and Faber, Jennifer and Paulson, Henry L and Öz, Gülin and Burns, Matthew R},
  title = {Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70116}
}
Kostenlos starten →